Top Clinical Trials companies in France by Total Non-Current Liabilities
France
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 102.27 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
| 2 |
USD 74.44 M
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
| 3 |
USD 67.34 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
| 4 |
USD 66.15 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
| 5 |
USD 56.77 M
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
| 6 |
USD 50.63 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
| 7 |
USD 44.46 M
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
| 8 |
USD 30.71 M
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
| 9 |
USD 26.31 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
| 10 |
USD 25.95 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
| 11 |
USD 21.64 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
| 12 |
USD 18.47 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
| 13 |
USD 17.88 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
| 14 |
USD 13.31 M
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
| 15 |
USD 12.08 M
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
| 16 |
USD 8.12 M
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
| 17 |
USD 5.46 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
| 18 |
USD 5.45 M
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
| 19 |
USD 3.36 M
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
| 20 |
USD 2.02 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest Total Non-Current Liabilities ?
The Clinical Trials company in France with the highest Total Non-Current Liabilities is Innate Pharma S.A. (Paris Stock Exchange: IPH.PA) at USD 102.27 M.
-
Which Clinical Trials company in France has the lowest Total Non-Current Liabilities ?
The Clinical Trials company in France with the lowest Total Non-Current Liabilities is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at USD 2.02 M.
-
What are the top 10 Clinical Trials companies in France by Total Non-Current Liabilities ?
The top 10 Clinical Trials companies in France by Total Non-Current Liabilities are Innate Pharma S.A., Genfit S.A., ABIVAX SA, MedinCell S.A., Inventiva S.A., Nanobiotix S.A., OSE Immunotherapeutics SA, AB Science S.A., Crossject SA and Median Technologies SA.
-
What are the bottom 10 Clinical Trials companies in France by Total Non-Current Liabilities ?
The bottom 10 Clinical Trials companies in France by Total Non-Current Liabilities are Eurofins-Cerep SA, Aelis Farma SA, Valbiotis SA, DBV Technologies S.A., Predilife S.A., MaaT Pharma SA, Adocia SA, Advicenne S.A., Affluent Medical SA and Novacyt S.A..
